Chinese Herbal Medicine
and Unresectable Hepatocellular Carcinoma
and Unresectable Hepatocellular Carcinoma
A study was conducted to investigate the effects of Chinese medicine
(CM) herbal treatment based on syndrome differentiation on patients with
unresectable hepatocellular carcinoma (HCC). A total of 94 patients with
unresectable HCC were reviewed between June 2008 and June 2011. Survival
analysis was performed between patients who received CM with/without
non-curative antitumor treatments of Western medicine (WM) (CM group, 30 cases)
and patients who were not treated with CM but with non-curative antitumor
treatments of WM or supportive treatment alone (non-CM group, 64 cases). Then,
survival analysis was performed between patients treated with CM combined with
non-curative antitumor treatments of WM (combination therapy group, 25 cases)
and patients with non-curative antitumor treatments of WM alone (non-curative
antitumor treatments group of WM, 52 cases). The survival analysis was
performed by Kaplan-Meier method and prognostic factors for overall survival
(OS) were assessed by the Cox proportional hazards regression model. The median
survival time (MST), 1- and 2-year survival rates of the CM group and the
non-CM group were 36 months, 76.7%, 56.1% and 12 months, 48.4%, 26.6%,
respectively. The Log-rank test revealed significant difference between the two
groups in OS (P<0.01). Cox proportional multivariate analysis revealed that
CM was an independent favorable prognostic factor for OS. The MST, 1- and
2-year survival rates of combination therapy group and non-curative antitumor
treatments group of WM were 36 months, 76.0%, 55.5% and 13 months, 55.8%,
30.8%, respectively. There was significant difference in OS between the two
groups (P=0.004). CM herbs based on syndrome differentiation have positive
effects on survival of patients with unresectable HCC. Furthermore, combination
therapy of CM and WM are recommended in HCC treatment.
Source: Man YN,
Liu XH,
Wu XZ.
Chinese medicine
herbal treatment based on syndrome differentiation improves the overall
survival of patients with unresectable hepatocellular carcinoma. Chin J Integr Med. 2015
Jan;21(1):49-57.
No comments:
Post a Comment